In the dense rainforests of Southeast Asia, a humble root holds secrets that could revolutionize how we combat one of the world's most pervasive health challenges.
Deep within the tropical forests of Indonesia, Malaysia, and surrounding regions grows Eurycoma longifolia Jack, a plant known locally as pasak bumi or tongkat ali. For centuries, traditional healers have harnessed its power for everything from fevers to fatigue. While often celebrated for its energizing and aphrodisiac properties, scientists are now uncovering a potentially more significant application: a natural ally in the fight against diabetes.
With over half a billion people affected worldwide and conventional treatments often accompanied by side effects and high costs, the search for effective natural alternatives has never been more urgent. Join us as we explore how this traditional remedy is being transformed through the lens of modern science.
Diabetes affects over 500 million people worldwide, creating an urgent need for effective treatments.
Centuries of traditional use provide a roadmap for modern scientific investigation.
Rigorous research is uncovering the biochemical basis for traditional applications.
Diabetes mellitus has reached epidemic proportions globally, affecting approximately 9.3% of the world's adult population in 2019 alone 4 . This chronic metabolic disorder, characterized by elevated blood glucose levels, can lead to severe complications including heart disease, kidney failure, and nerve damage.
The economic and personal burdens of diabetes have fueled scientific interest in plant-based treatments that are more accessible and have fewer side effects than conventional pharmaceuticals. According to the World Health Organization, an astonishing 70% of people worldwide rely on medicinal plants for their primary healthcare needs 2 . This traditional wisdom, passed down through generations, now serves as a valuable roadmap for modern drug discovery.
of adults worldwide affected by diabetes
rely on medicinal plants for primary healthcare
Eurycoma longifolia Jack is a slender, shrubby tree belonging to the Simaroubaceae family, native to Southeast Asian countries 5 . While all parts of the plant have traditional medicinal uses, the roots contain the highest concentration of bioactive compounds and are the most extensively studied.
The most abundant and biologically active compounds
Canthin-6-one and β-carboline alkaloids
Tirucallane type compounds
Bioactive steroids and squalene derivatives
Plant-derived compounds can address diabetes through several distinct biological mechanisms. Based on research into similar medicinal plants, the key antidiabetic effects include:
Compounds that inhibit carbohydrate-digesting enzymes like α-amylase and α-glucosidase in the digestive system, slowing the breakdown of complex carbohydrates into simple sugars and thereby reducing post-meal blood glucose spikes 4 .
Protection of insulin-producing β-cells in the pancreas from damage and potentially stimulating their regeneration, crucial for maintaining the body's natural insulin production 2 .
Neutralization of harmful free radicals and reduction of oxidative stress, which plays a significant role in diabetes development and progression 4 .
While comprehensive antidiabetic studies specifically on pasak bumi roots are still emerging in scientific literature, we can construct a rigorous experimental framework based on established protocols used for similar medicinal plants like Berberis orthobotrys 2 and Octhochloa compressa 9 . Such a study would aim to scientifically validate traditional knowledge and determine optimal dosing and safety profiles.
The process begins with the careful preparation of plant material. Roots would be harvested, cleaned, sliced, and dried, then ground into a fine powder. Different extraction methods would be tested—including water, ethanol, and methanol extraction—to determine which solvent most effectively pulls out the bioactive compounds. The extract would then be concentrated using a rotary evaporator and prepared for testing 1 .
Before moving to living organisms, preliminary tests would assess the extract's ability to inhibit carbohydrate-digesting enzymes (α-amylase and α-glucosidase), evaluate its antioxidant capacity, and determine general safety parameters 9 .
Animal models provide critical information about how the extract behaves in a living system. Diabetes would be induced in laboratory rats using substances like alloxan or streptozotocin, which selectively damage insulin-producing pancreatic cells. The diabetic animals would then be divided into several groups:
The treatment would typically last 21-28 days, with regular monitoring of blood glucose levels and observation for any adverse effects 2 6 .
At the end of the study period, comprehensive analysis would include:
Based on similar studies with other medicinal plants 2 9 , we would anticipate results showing dose-dependent reductions in blood glucose levels, with higher doses potentially producing effects comparable to standard antidiabetic medications.
| Experimental Group | Day 0 | Day 7 | Day 14 | Day 21 | Day 28 |
|---|---|---|---|---|---|
| Normal Control | 85.2 ± 4.3 | 86.7 ± 3.9 | 84.9 ± 4.1 | 87.2 ± 3.7 | 85.8 ± 4.0 |
| Diabetic Control | 328.5 ± 12.7 | 335.2 ± 11.9 | 341.7 ± 13.5 | 338.9 ± 12.3 | 332.4 ± 14.1 |
| Standard Drug | 321.8 ± 10.4 | 285.3 ± 9.7 | 214.6 ± 8.9 | 158.3 ± 7.5 | 121.6 ± 6.8 |
| Pasak Bumi (Low Dose) | 315.7 ± 11.2 | 298.4 ± 10.8 | 270.5 ± 9.3 | 235.7 ± 8.6 | 204.3 ± 7.9 |
| Pasak Bumi (Medium Dose) | 324.6 ± 13.5 | 290.1 ± 12.1 | 245.8 ± 10.7 | 189.4 ± 9.2 | 145.2 ± 8.4 |
| Pasak Bumi (High Dose) | 319.8 ± 12.9 | 275.6 ± 11.7 | 218.9 ± 10.2 | 167.3 ± 8.8 | 128.9 ± 7.3 |
| Parameter | Normal Control | Diabetic Control | Standard Drug | Pasak Bumi (High Dose) |
|---|---|---|---|---|
| HbA1c (%) | 4.8 ± 0.3 | 9.7 ± 0.5 | 6.2 ± 0.4 | 6.8 ± 0.4 |
| Total Cholesterol (mg/dL) | 155.3 ± 8.7 | 228.6 ± 12.4 | 172.5 ± 9.3 | 180.3 ± 9.8 |
| Triglycerides (mg/dL) | 142.6 ± 7.9 | 215.7 ± 11.8 | 158.3 ± 8.5 | 165.2 ± 8.9 |
| Body Weight (g) | 245.7 ± 12.5 | 198.4 ± 10.3 | 230.8 ± 11.7 | 225.6 ± 11.2 |
The anticipated results would likely demonstrate significant improvements in multiple metabolic parameters beyond just blood glucose control, suggesting comprehensive metabolic benefits.
While our focus has been on diabetes, research has revealed that pasak bumi possesses a remarkable range of biological activities:
Studies have demonstrated that pasak bumi root extract can induce apoptosis (programmed cell death) in prostate cancer cells and modulate critical cancer-related pathways like PTEN/PI3k/Akt 1 3 . The extract has shown concentration-dependent effects, with higher concentrations exhibiting more pronounced anticancer activity.
The root extract has demonstrated the ability to reduce pro-inflammatory cytokines like IL-6 and TNF-α in animal studies, indicating broad anti-inflammatory potential 8 .
Despite promising findings, several challenges remain in fully realizing pasak bumi's therapeutic potential:
The scientific journey of pasak bumi from traditional remedy to subject of rigorous laboratory investigation exemplifies the growing recognition of nature's pharmacy. While comprehensive antidiabetic studies specifically on its roots represent an exciting frontier, the existing evidence from related research and documented biological activities provides compelling reasons for continued exploration.
As we stand at the intersection of traditional knowledge and modern science, plants like pasak bumi offer hope not only for developing new treatments but for understanding the intricate relationship between plants and human health. The future may very well see this humble root take its place not just in the forests of Southeast Asia, but in the global arsenal against diabetes and other metabolic diseases.
"The goal of gene-targeted therapy is to restore gene expression changes in cancer, bringing it back to a normal genomic condition" 1 . Perhaps this philosophy extends to diabetes as well—using nature's intelligence to restore our own biological balance.